Thomas Radimerski
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 2%
- Immunology top 5%
- Aging top 0.5%
- Oncology top 10%
- Co-authors
- Jacques MontagneErnst HafenGeorge ThomasHugo StockerSophie RaisinJulien ColombaniSophie PantalacciPierre Léopold
- Topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers)Cytokine Signaling Pathways and Interactions (12 papers)Kruppel-like factors research (9 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Thomas Radimerski
41 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 2.1k
- Cellular and Molecular Neuroscience 807
- Immunology 528
- Aging 438
- Oncology 358
Countries citing papers authored by Thomas Radimerski
This map shows the geographic impact of Thomas Radimerski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Radimerski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Radimerski more than expected).
Fields of papers citing papers by Thomas Radimerski
This network shows the impact of papers produced by Thomas Radimerski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Radimerski. The network helps show where Thomas Radimerski may publish in the future.
Co-authorship network of co-authors of Thomas Radimerski
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Radimerski. A scholar is included among the top collaborators of Thomas Radimerski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Radimerski. Thomas Radimerski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 18 | |
| 3 | 33 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 59 | |
| 7 | 21 | |
| 8 | 193 | |
| 9 | 50 | |
| 10 | 21 | |
| 11 | 15 | |
| 12 | 33 | |
| 13 | 43 | |
| 14 | 71 | |
| 15 | 419 | |
| 16 | A Nutrient Sensor Mechanism Controls Drosophila Growthbreakdown → | 599 |
| 17 | 480 | |
| 18 | 149 | |
| 19 | 153 | |
| 20 | 351 |
About Thomas Radimerski
Thomas Radimerski is a scholar working on Genetics, Hematology and Oncology, having authored 41 papers that have together received 3.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Cytokine Signaling Pathways and Interactions (12 papers) and Kruppel-like factors research (9 papers). The work is most often cited by research in Aging (438 citations), Cellular and Molecular Neuroscience (807 citations) and Molecular Biology (2.1k citations). Thomas Radimerski has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Jacques Montagne, Ernst Hafen, George Thomas, Hugo Stocker, Sophie Raisin, Julien Colombani, Sophie Pantalacci, Pierre Léopold, Felix Rintelen and Sean Oldham. Their work appears in journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.